Literature DB >> 11168391

delta(9)-Tetrahydrocannabinol increases nerve growth factor production by prostate PC-3 cells. Involvement of CB1 cannabinoid receptor and Raf-1.

L Velasco1, L Ruiz, M G Sánchez, I Díaz-Laviada.   

Abstract

Cannabinoids, the active components of marihuana, exert a variety of effects in humans. Many of these effects are mediated by binding to two types of cannabinoid receptor, CB1 and CB2. Although CB1 is located mainly in the central nervous system, it may also be found in peripheral tissues. Here, we study the effect of cannabinoids in the production of nerve growth factor by the prostate tumor cell line PC-3. We show that addition of Delta(9)-tetrahydrocannabinol to PC-3 cells stimulated nerve growth factor production in a dose-dependent and time-dependent manner. Maximal effect was observed at 0.1 microM Delta(9)-tetrahydrocannabinol and 72 h of treatment. Stimulation was reversed by the CB1 antagonists AM 251 and SR 1411716A. Pre-treatment of cells with pertussis toxin also prevented the effect promoted by Delta(9)-tetrahydrocannabinol. These results indicate that Delta(9)-tetrahydrocannabinol stimulation of nerve growth factor production in these cells was mediated by the cannabinoid CB1 receptor. The implication of Raf-1 activation in the mode of action of Delta(9)-tetrahydrocannabinol is also suggested.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11168391     DOI: 10.1046/j.1432-1327.2001.01884.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  10 in total

1.  Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro-apoptotic effects and underlying mechanisms.

Authors:  Luciano De Petrocellis; Alessia Ligresti; Aniello Schiano Moriello; Mariagrazia Iappelli; Roberta Verde; Colin G Stott; Luigia Cristino; Pierangelo Orlando; Vincenzo Di Marzo
Journal:  Br J Pharmacol       Date:  2013-01       Impact factor: 8.739

2.  Inhibition by anandamide of 6-hydroxydopamine-induced cell death in PC12 cells.

Authors:  Katarzyna Mnich; David P Finn; Eilis Dowd; Adrienne M Gorman
Journal:  Int J Cell Biol       Date:  2010-02-16

Review 3.  The endocannabinoid system and cancer: therapeutic implication.

Authors:  Josée Guindon; Andrea G Hohmann
Journal:  Br J Pharmacol       Date:  2011-08       Impact factor: 8.739

Review 4.  The Endocannabinoid System: A Potential Target for the Treatment of Various Diseases.

Authors:  Henry Lowe; Ngeh Toyang; Blair Steele; Joseph Bryant; Wilfred Ngwa
Journal:  Int J Mol Sci       Date:  2021-08-31       Impact factor: 6.208

5.  Cannabinoids selectively inhibit proliferation and induce death of cultured human glioblastoma multiforme cells.

Authors:  Sean D McAllister; Calvin Chan; Ryan J Taft; Tri Luu; Mary E Abood; Dan H Moore; Ken Aldape; Garret Yount
Journal:  J Neurooncol       Date:  2005-08       Impact factor: 4.130

6.  Expression of cannabinoid receptors and neurotrophins in human gliomas.

Authors:  C Calatozzolo; A Salmaggi; B Pollo; F L Sciacca; M Lorenzetti; A Franzini; A Boiardi; G Broggi; C Marras
Journal:  Neurol Sci       Date:  2008-01-04       Impact factor: 3.307

7.  Characterization of an anandamide degradation system in prostate epithelial PC-3 cells: synthesis of new transporter inhibitors as tools for this study.

Authors:  Lidia Ruiz-Llorente; Silvia Ortega-Gutiérrez; Alma Viso; María G Sánchez; Ana M Sánchez; Carlos Fernández; José A Ramos; Cecilia Hillard; Miguel A Lasunción; María L López-Rodríguez; Inés Díaz-Laviada
Journal:  Br J Pharmacol       Date:  2004-01-12       Impact factor: 8.739

Review 8.  Prejunctional and peripheral effects of the cannabinoid CB(1) receptor inverse agonist rimonabant (SR 141716).

Authors:  Hester van Diepen; Eberhard Schlicker; Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-07-25       Impact factor: 3.000

Review 9.  Cannabinoids as therapeutic agents in cancer: current status and future implications.

Authors:  Bandana Chakravarti; Janani Ravi; Ramesh K Ganju
Journal:  Oncotarget       Date:  2014-08-15

10.  Psychosocial stress and cannabinoid drugs affect acetylation of α-tubulin (K40) and gene expression in the prefrontal cortex of adult mice.

Authors:  Jordi Tomas-Roig; Shyam Ramasamy; Diana Zbarsky; Ursula Havemann-Reinecke; Sigrid Hoyer-Fender
Journal:  PLoS One       Date:  2022-09-21       Impact factor: 3.752

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.